Table 1. Correlations between miR-132 and Bmi-1 expression and clinicopathological characteristics in cervical carcinoma patients.

Clinicopathological characteristic	miRNA-132		Bmi-1*		χ2 / *χ2	p / *p
	Low	High	Low	High
Age (years)
< 45	16	20	22	14	0.936/*2.270	0.333/*0.132
≥ 45	37	31	31	37
Tumor maximum diameter (cm)
< 4	26	40	42	24	9.672/*11.610	0.002/*0.001
≥ 4	27	11	11	27
FIGO stage
Ib ∼ IIa	24	40	40	24	12.070/*8.865	0.001/*0.003
IIb ∼ IIIa	29	11	13	27
Differentiation
Highly-differentiated	27	41	42	26	9.959/*9.174	0.002/*0.003
Poorly- and moderately-differentiated	26	10	11	25
Lymph node metastasis
Yes	17	18	18	17	0.121/*0.005	0.728/*0.946
No	36	33	35	34
SCC-Ag(ng / ml)
< 1.5	27	34	31	30	2.650/*0.001	0.104/*0.973
≥ 1.5	26	17	22	21

Note: miR-132, microRNA-132; FIGO, International Federation of Gynecology and Obstetrics; SCC-Ag, squamous cell carcinoma antigen.